Catholic Health Initiatives Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2013
NCT02102555
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Catholic Health Initiatives

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Disease Progression (Phase 2)

Nausea (Phase 3)

Pain, Postoperative (Phase 3)

Postoperative Nausea and Vomiting (Phase 3)

Vomiting (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 13